Search results
Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by J.W. Cole Advisors Inc.
ETF DAILY NEWS· 4 days agoJ.W. Cole Advisors Inc. boosted its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 9.5% in the 4th quarter, Holdings Channel reports. The ...
Bristol-Myers Squibb (NYSE:BMY) Short Interest Down 5.7% in March
ETF DAILY NEWS· 7 days agoAs of March 31st, there was short interest totalling 35,120,000 shares, a decline of 5.7% from the March 15th total of 37,250,000 shares. A number of research analysts recently commented on ...
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply...
Morningstar· 3 days agoBristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring ...
Zhang Financial LLC Has $207,000 Position in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 4 days agoZhang Financial LLC lessened its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.9% during the fourth quarter, according to its most ...
Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt?
Simply Wall St. via Yahoo Finance· 3 days agoWhen we think about how risky a company is, we always like to look at its use of debt, since debt...
FY2024 EPS Estimates for Bristol-Myers Squibb (NYSE:BMY) Reduced by William Blair
ETF DAILY NEWS· 7 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Stock analysts at William Blair lowered their FY2024 earnings per share (EPS) estimates for Bristol ...
Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
Zacks· 7 days agoFree Report) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in ...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 10 hours agoBMY’s newer products like Reblozyl, Breyanzi, Zeposia and Opdualag are likely to have also...
Bristol-Myers Squibb Co. (NYSE: BMY) Stock: Does It Have More Upside? – Marketing Sentinel
Marketing Sentinel· 1 day agoAmong the rest, 11 recommended BMY as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Bristol-Myers Squibb Co. is expected to report earnings ...
3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations
Motley Fool via Yahoo Finance· 5 days agoHere's why these dividend stocks are worth buying right now. Bristol Myers Squibb: 4.8% Shares of ...